Sign in

CIK 0001590877 · Non-accelerated filer<br>Smaller reporting company

REGENXBIO Inc.

Sign in to watch
Ticker
RGNX
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Entity type
operating
EIN
471851754
Phone
240-552-8181
Business address
9804 MEDICAL CENTER DRIVE, ROCKVILLE, MD, 20850
Former names
ReGenX Biosciences, LLC
  1. 3 Insider Initial Statement of Ownership
  2. 3 Insider Initial Statement of Ownership
  3. 3 Insider Initial Statement of Ownership
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 3 Insider Initial Statement of Ownership
  9. CERTNAS Other Certification by the Nasdaq Stock Market
  10. S-1/A Offering Registration Statement
  11. S-1/A Offering Registration Statement
  12. CORRESP Other Correspondence Between Filers and SEC Staff
  13. CORRESP Other Correspondence Between Filers and SEC Staff
  14. 8-A12B Other Registration of Securities
  15. S-1/A Offering Registration Statement
  16. CORRESP Other Correspondence Between Filers and SEC Staff
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. UPLOAD Other SEC-generated Letter
  19. S-1 Offering Registration Statement
  20. DRSLTR Other Correspondence Related to Draft Registration Statement

Page 40 of 41 · 806 filings